Clinical evaluation of Jirakadyarishta in the management of Grahani

Central Council for Research in Ayurvedic Sciences CCRAS New Delhi0 个研究点目标入组 51 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Patients of either sex aged 18-65 years
•2.Known cases of Grahani (diagnostic criteria as per classical Ayurvedic parameters)
•a) Chronic or recurrent abdominal discomfort or pain
•b) Abdominal bloating
•c) Constipation
•d) Diarrhoea
•e) Urgency of bowel movements
•f) Feeling of incomplete evacuation
•g) Passage of mucus
•3.Patients willing to give written informed consent and able to participate for 3 months.

•1.Patients with history of Inflammatory Bowel Disease (IBD), KochÃ¢â?¬•s abdomen, Gluten intolerance.
•2.Patients with history of chronic Amoebiasis.
•3.Known cases of Diabetes Mellitus.
•4.Patients with poorly controlled Hypertension ( >160/100 mmHg)
•5.Patients who have history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months
•6.Symptomatic patients with clinical evidence of Heart failure
•7.Known cases of malignancy
•8.Patients with concurrent serious hepatic disorders (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease (COPD).
•9.Women who are planning for conception / pregnant or lactating.
•10.H/o hypersensitivity to any of the trial drugs or their ingredients
•11.Patients who have completed participation in any other clinical trial during the past three months
•12.Any other condition which the Investigator thinks may jeopardize the study

发起方

Central Council for Research in Ayurvedic Sciences CCRAS New Delhi